terbutaline has been researched along with Abnormalities, Multiple in 1 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with terbutaline, a Na/K-ATPase-stimulating drug, resulted in attack-free periods of approximately 9 months, after which the attacks reoccurred." | 1.30 | Multiple anomalies, hypokalaemic paralysis and partial symptomatic relief by terbutaline. ( Andersen, PE; Djurhuus, MS; Jensen, BM; Klitgaard, NA; Schrøder, HD, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djurhuus, MS | 1 |
| Klitgaard, NA | 1 |
| Jensen, BM | 1 |
| Andersen, PE | 1 |
| Schrøder, HD | 1 |
1 other study available for terbutaline and Abnormalities, Multiple
| Article | Year |
|---|---|
Multiple anomalies, hypokalaemic paralysis and partial symptomatic relief by terbutaline.
Topics: Abnormalities, Multiple; Arrhythmias, Cardiac; Child; Fatal Outcome; Humans; Hypokalemia; Male; Mand | 1998 |